TOP BUSINESS NEWS
-
Press Release:
World’s first ever dynamic Portal – www.PharmaTechnologyIndex.com on Exclusive Pharmaceutical Technology Industry, is Marching Ahead :
It is irrefutable that today’s market scenario depicts con...
-
Glenmark enters into a settlement and license agreement with Sepracor Inc
Aug 11, 2010
US specialty pharmaceutical company Sepracor Inc, owned by Japan's Dainippon Sumitomo Pharma Co since April, and Mumbai-based Generics maker Glenmark have announced the settlement of...
-
Calculating risk-taker
August 5, 2010
Sudhir Mehta has taken the Torrent Group into ever-newer areas. What started in the early 1970s as Trinity Laboratories has turned into a $1.41 billion global business conglomerate wit...
-
MNCs gaining control on Indian drug market
August 5, 2010
The parliamentary standing committee on health has asked the government to pay attention to the selling out of major Indian Pharma companies to multinationals, whose increasing hold ov...
-
Glenmark launches pain relief drug in US
August 2, 2010
Pharma major Glenmark Generics on Monday commenced marketing and distribution of Cyclobenzaprine Hydrochloride tablets in the US market.
Cyclobenzaprine Hydrochloride tablets are a ...
-
Global bids issued for advisor to strengthen pharma in India
August 2, 2010
With an objective to make India a destination for drug discovery and strengthen the pharma infrastructure, global bids for selection of a
Consultant as part of the 'Pharma Vision 2020...
-
Robust ANDA pipeline to help Sun Pharma sustain US growth
August 2, 2010
Sun Pharma’s first quarter results reflect the way the fortunes of generic Indian pharma companies swing from quarter to quarter due to one-time income earned from exclusive launch o...
-
Drug Dealer Ventures into Production
July 19, 2010
Over 550,000 small drug retailers in the country are transforming into producers and marketers of pharmaceutical products, readying to compete with companies such as Ranbaxy, Cipla, Sun...
-
Govt plans Rs 10k-cr VC fund to promote R&D in pharma
July 19, 2010
The government is planning to set up a Rs 10,000-crore venture capital (VC) fund for financing new drug discovery projects in the country.
"We will soon invite bids from consultanc...
-
State support to pharma firms to help in developing new TB drugs
July 17, 2010
Drug development to treat tuberculosis will depend on some sort of advance commitment from government agencies to procure anti-TB drugs from pharmaceutical companies which otherwise hav...
EVENTS
July 17, 2010 In order to educate the indenting agents regarding their role under the Drugs and Cosmetics Act, the recently formed All India Pharma Indenting Agents Association will hold... Readmore |
 The Pharmaceutical Export Promotion Council (Pharmexcil), an autonomous trade promotion body under the aegis of the Ministry of Commerce and Industry, Government of India, will lead a delegation of six... Readmore |
 As part of a series of measures to counter the multinational companies'(MNCs) propaganda against the Indian generic drugs in the African countries, the Union Commerce Ministry will soon embark on... Readmore |
 HarNeedi.com, India’s No. 1 job portal for Healthcare and Pharma industry, will be organizing an exclusive ‘Healthi Job Fair 2010’ for Healthcare and Pharma 'Healthi Job Fair 2010' at the... Readmore |
 Pharmintech, the international exhibition for technology, materials and services for the processing and packaging of pharmaceutical, personal care and nutraceutical products is scheduled to take place at BolognaFiere from May... Readmore |
|
More in: International, National, Domestic
|
BIOTECHNOLOGY
 Aug 11, 2010Genzyme Corp., which is locked in merger talks with French drug maker Sanofi-Aventis SA, is not the first major Massachusetts biotechnology company to be pursued by a major... Readmore |
Mumbai outpaced Bangalore, with a small margin of about Rs. 200 crore, to become India’s Top Biotech City in terms of revenue while Bangalore-based biopharmaceuticals firm Biocon, known for... Readmore |
 Bangalore-based biopharmaceutical start-up Biovel Lifesciences is looking to exit from the life sciences space and is keen for an early outright buyout. Biovel has been in dialogue with several companies... Readmore |
 Sanofi-aventis, the world's leading vaccine manufacturer, officially launched the construction of a new Sanofi Pasteur vaccine manufacturing centre in Neuville-sur-Saône, France. Readmore |
 The pharmaceutical and biotechnology industry is in the process of consolidating and down-sizing while trying to maintain R&D productivity. Small and medium-sized companies are trying to make the most... Readmore |
|
More in: Biotechnology
|
DEAL WATCH
 August 5, 2010 Pankaj Patel has used acquisitions and alliances to take the group to the next level. Pankaj R Patel is chairman and managing director of the Zydus Cadila... Readmore |
 July 17, 2010 Endo Pharmaceuticals announced the completion of its acquisition of HealthTronics, Inc., a leading US provider of urological products and services, located in Austin, Texas. Endo acquired HealthTronics... Readmore |
 July 17, 2010 Watson Pharmaceuticals, Inc. announced an exclusive, worldwide licensing agreement with Itero Biopharmaceuticals, Inc., a venture-backed specialty biopharmaceutical company, to develop and commercialize Itero's Recombinant Follicle Stimulating... Readmore |
 July 17, 2010 Generic and specialty drugmaker Milan Inc. (NYSE: MYL) has agreed to buy injectable drug company Bioniche Pharma Holdings Ltd. for $550 million in cash, gaining the Pittsburgh,... Readmore |
 July 17, 2010Indian Pharma major Dr Reddy Laboratories signed an agreement with Alchemia, an Australian Pharmaceutical company, for marketing Fondaparinux sodium for injection in all markets outside of North America.... Readmore |
|
More in: Deal Watch
|
COMPANY PROFILES
1.Indian Institute of Toxicology - Indian Institute of Toxicology (IIT) is one of the pioneers, independent Contract Research Organization (CRO) engaged in toxicology and has been in the business for the past 25 Years. The institute is committed to excellence, which is borne out of a State-of-art infrastructure & technical skills in the field of Toxicology Studies.... [English]-[French]-[Spanish]
|
|
|
|
|
EMERGING MARKETS
 August 12, 2010 Pharmaceutical major Aurobindo Pharma is gearing up to make an aggressive foray into the institutional supply market in the US. Though it has already started raking in... Readmore |
 August 2, 2010 Dr Reddy’s Laboratories (DRL) is scouting for partners in Japan to explore the $80-billion generic drug market. Japan is the second-largest pharmaceutical market in the world. GV... Readmore |
Indian pharmaceutical companies have expressed keen interest to set up units in Russia for producing generic drugs, which will give a fillip to the growing economic partnership between the two... Readmore |
 Emerging markets such as India and China are set to overtake major developed drug markets of the world, with significant increase in pharmaceutical sales through 2013, says a study.... Readmore |
 AstraZeneca lifted the veil a bit today on its plans to become a bigger player in emerging markets, saying sales in those those countries will double to account for about... Readmore |
|
More in: Emerging Markets
|
PRODUCTS
 July 3, 2010 Watson Pharmaceuticals, Inc. announced that, under a settlement with Novartis Pharmaceuticals Corporation, Novartis Pharma AG, Novartis AG, Novartis International Pharmaceutical Ltd., and Proterra AG (collectively Novartis),... Readmore |
 Pharma major Ranbaxy Laboratories Friday said it will launch anti-diabetic drug Actos in the US by 2012.
Readmore |
 Caraco Pharmaceutical Laboratories Ltd, a unit of Sun Pharmaceutical Industries Ltd, said late on Thursday it has launched the generic version of anti-cancer drug oxaliplatin in injection form in the... Readmore |
 Its breast cancer drug, Albupax, will have to clear quality tests at government labs before it can re-enter the market.
Readmore |
 Pharma major Ranbaxy Laboratories today said it has launched a new dermatological product Lulifin in the Indian market. This follows a strategic in-licensing agreement with Summit Pharmaceuticals International Corporation, Japan,... Readmore |
|
More in: Products
|
FEATURED ARTICLES
 Indian Pharma Companies Eye High Potency API Market Pie
The Indian Active Pharmaceutical Ingredient (API) Industry is fast developing though many challenges exist as it....[English]-[French]-[Spanish] Indian Biogenerics Firms Poised to Storm Western Markets
With blockbuster first-generation biotherapeutics developed in the West are losing patent protection, Indian biopharma...[English] [French] [Spanish]
CLINICAL TRIALS
 August 2, 2010 Isis Pharmaceuticals Inc will soon release key data from pivotal trials of its experimental cholesterol drug that will be closely parsed for evidence of any safety risks,... Readmore |
Trubion Pharmaceuticals, Inc. announced Pfizer's decision to discontinue development of TRU-015 (PF-05212374), an investigational drug in phase 2 evaluation for the treatment of rheumatoid arthritis (RA) developed under the... Readmore |
 Cadila Pharmaceuticals’ plan to indigenously develop Influenza A HINI (swine flu) vaccine in collaboration with US-based Novavax is likely to be delayed as the government has shown caution in giving... Readmore |
 Pharma major Dr Reddy’s Laboratories Ltd., (DRL), on Monday, announced results from the first phase III trials of its chemical entity, Balaglitazone, an insulin sensitizer used in the treatment of... Readmore |
Pharma major Dr Reddy's Laboratories (DRL) is gearing up for taking its new anti-cholesterol drug to Phase II trials. Readmore |
|
More in: Clinical Trials
|
HEALTH CARE WATCH
Rheumatoid arthritis sufferers in England and Wales will gain access to an extra drug through the NHS to combat the condition.
Readmore |
 Franchise India Holdings limited in association with Francorp and Medium Healthcare Consulting Pvt Ltd has organized a two day workshop on Business of Healthcare, Wellness and Beauty at Taj Lands... Readmore |
 Painkillers may help relieve pain, but as with most things, too much of the drugs is bad for health. Some learn it the hard way. Readmore |
 In what seems to be an alarming situation for the national health, India ranks highest in the list of Tuberculosis (TB) inflicted countries worldwide, as unveiled by the Union Ministry... Readmore |
 India's healthcare sector is expected to grow at 23 per cent annually to become a $77-billion industry by 2012, according to a recent report. Readmore |
|
More in: Doctors Speak, Health Insights
|
FDA
 August 2, 2010 Despite stringent approval systems in regulated markets, Indian pharmaceutical companies have been able to obtain increasing number of drug approvals from the US FDA during last few... Readmore |
 August 2, 2010 Drug maker, Aurobindo Pharma announced that it has received final approval from US Food & Drug Administration (USFDA) for Ranitidine Syrup (Ranitidine oral solutions) in the strengths... Readmore |
July 3, 2010 Par Pharmaceutical Cos Inc (PRX.N) said U.S. health regulators have approved its drug to prevent nausea and vomiting in patients who are treated for cancer. The... Readmore |
 The U.S. Food and Drug Administration unveiled a new initiative to accelerate the development of cocktail drugs to treat tuberculosis (TB).
Readmore |
 Lupin received a US Food and Drug Administration tentative approval for an insomnia drug, the company told pharmaquest.biz. This is Lupin’s second approval this week and sixth this year.... Readmore |
|
More in: International
|
|
